Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Veliko Tirnovo

82 clinical trials in Veliko Tirnovo, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Veliko Tirnovo at a glance
82
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

82 trials in Veliko Tirnovo

Open in trial search

Cardiac failure

Recruiting

Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+2

Recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:PF-07275315
  • Sponsor:Pfizer Inc.

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

Crohn's disease

Recruiting

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Recruiting

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Veliko Tirnovo

What the registry says about research in the country

01 Cardiovascular Research

Extensive studies focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Research includes evaluation of new medications for reducing cardiovascular events and managing blood lipid levels.

  • Deep Vein Thrombosis Treatment
  • Stroke Prevention in Atrial Fibrillation
  • Heart Failure Management

Trials are investigating novel approaches to cholesterol management and prevention of major adverse cardiovascular events.

02 Respiratory Medicine

Advanced research into chronic obstructive pulmonary disease (COPD) treatments and respiratory infections. Studies evaluate new therapeutic combinations and treatment efficacy.

  • COPD Treatment Optimization
  • Respiratory Syncytial Virus Therapy
  • Lung Function Improvement

Focus on developing improved inhalation therapies and testing new drug formulations for respiratory conditions.

03 Gastroenterology Studies

Innovative research in treating ulcerative colitis and inflammatory bowel conditions. Multiple trials exploring combination therapies and long-term treatment options.

  • Moderate to Severe Ulcerative Colitis
  • Novel Treatment Combinations
  • Long-term Disease Management

Emphasis on developing sustainable treatment approaches for chronic gastrointestinal conditions.

04 Mental Health Research

Comprehensive studies on major depressive disorder and other psychiatric conditions. Investigation of new therapeutic approaches for mental health management.

  • Schizophrenia Treatment
  • Bipolar Disorder Management
  • Depression Therapy

Focus on long-term safety and efficacy of new psychiatric medications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.